Nanostructured mucoadhesive microparticles for enhanced preocular retention
Source abstract
Abstract
We describe nanostructured microparticles (NMs) containing a mucoadhesive polymer for enhanced preocular retention and consider them as potential carriers of drugs to the eye. These NMs are each composed of entangled nanofibers to give an enlarged specific surface area, and thus can better adhere to the preocular mucus surface. This physical design allows the microparticles still to be composed mainly of a wall material, poly(lactic-co-glycolic acid), as required for controlled drug delivery, while the effects of an additive, mucoadhesive material, polyethylene glycol, can be synergistically improved via the nanostructured morphology. Thus, when formulated in a dry tablet dosage form, the NMs in this work show more than a 10-fold increase in preocular retention in vivo compared to conventional spherical microparticles. Therefore, we conclude that these mucoadhesive NMs can reside on the preocular surface for a prolonged period, and thus appear to be a promising system for topical drug delivery to the eye.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Ocular Surface and Contact Lens · Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Ocular drug delivery10.1517/17425247.3.2.275 ↗
2. Ophthalmic drug delivery: development and regulatory considerations10.1038/clpt.2008.297 ↗
3. Comparison of two artificial tear formulations using aberrometry10.1111/j.1444-0938.2009.00373.x ↗
4. Effect of viscosity on tear drainage and ocular residence time10.1097/OPX.0b013e3181824dc4 ↗
5. Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery10.1016/j.ejpb.2011.11.013 ↗
6. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups10.1002/jps.10371 ↗
7. Alginate inserts loaded with epidermal growth factor for the treatment of keratoconjunctivitis sicca10.1080/10837450801949566 ↗
8. Review on ocular inserts
9. Recent developments in ophthalmic drug delivery10.1016/S1461-5347(98)00087-X ↗
10. Novel drug delivery systems for glaucoma10.1038/eye.2011.82 ↗
11. Review of ocular drug delivery10.2174/156720106776359186 ↗
12. The rise and rise of drug delivery10.1038/nrd1721 ↗
13. Microspheres and nanoparticles used in ocular delivery systems10.1016/0169-409X(95)00017-2 ↗
14. Polymeric nanoparticulate system: a potential approach for ocular drug delivery10.1016/j.jconrel.2008.12.018 ↗
15. Bioadhesive microspheres as a controlled drug delivery system10.1016/S0378-5173(03)00087-5 ↗
16. Mucoadhesive microspheres for controlled drug delivery10.1248/bpb.27.1717 ↗
17. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies10.1016/j.ejpb.2003.10.018 ↗
18. Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time10.1167/iovs.08-2515 ↗
19. Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye10.1167/iovs.10-6465 ↗
20. Formation and stability of nano-emulsions10.1016/j.cis.2003.10.023 ↗
21. Preparation of double emulsions by membrane emulsification—a review10.1016/j.memsci.2004.12.013 ↗
22. Particle formation in spray drying10.1016/j.jaerosci.2007.04.005 ↗
23. Spray drying of biopharmaceuticals: stability and process considerations10.1080/03602550600685275 ↗
24. Preparation and evaluation of w/o/w type emulsions containing vancomycin10.1016/S0169-409X(00)00097-1 ↗
25. Thermal stability of prednisone drug and tablets10.1023/A:1011500629494 ↗
26. Electrospinning: a fascinating method for the preparation of ultrathin fibres10.1002/anie.200604646 ↗
27. Ocular preparations: the formulation approach10.1081/DDC-120003445 ↗
28. A nanofibrous sheet-based system for linear delivery of nifedipine10.1016/j.jconrel.2010.10.023 ↗
29. Effect of cryo-milling on starches: functionality and digestibility10.1016/j.foodhyd.2009.08.013 ↗
30. Relationships between CO2 sorption capacity by coals as measured at low and high pressure and their swelling10.1016/j.coal.2011.11.012 ↗
31. Comparative oxidation of adsorbed asphaltenes onto transition metal oxide nanoparticles10.1016/j.colsurfa.2011.03.049 ↗
32. Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application10.1007/s10856-010-4213-3 ↗
33. Physico-chemical characterization of lignins from different sources for use in phenol–formaldehyde resin synthesis10.1016/j.biortech.2006.05.042 ↗
34. Spectroscopic studies of Nile red in organic solvents and polymers10.1016/1010-6030(95)04140-0 ↗
35. Spectrofluorometric studies of the lipid probe, Nile Red10.1016/S0022-2275(20)34307-8 ↗
36. Synthesis and characterization of SiO2–PEG hybrid materials10.1016/j.jnoncrysol.2005.11.033 ↗
37. Preparation and characterization of cross-linking PEG/MDI/PE copolymer as solid–solid phase change heat storage material10.1016/j.solmat.2007.01.011 ↗
38. Fabrication and characterization of aligned nanofibrous PLGA/Collagen blends as bone tissue scaffolds10.1016/j.polymer.2009.05.035 ↗
39. Control of osteogenic differentiation and mineralization of human mesenchymal stem cells on composite nanofibers containing poly [lactic-co-(glycolic acid)] and hydroxyapatite10.1002/mabi.200900169 ↗
40. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?10.1038/eye.1999.17 ↗
41. Precorneal retention of topically instilled micronized particles10.1002/jps.2600690735 ↗
42. A mathematical model for ocular tear and solute balance10.1080/02713680591004077 ↗
43. Biomimetic nanowire coatings for next generation adhesive drug delivery systems10.1021/nl803219f ↗
44. Evaluation of a mucoadhesive tablet for ocular use10.1016/S0168-3659(01)00522-3 ↗
45. The use of mucoadhesive polymers in ocular drug delivery10.1016/j.addr.2005.07.005 ↗
46. Accuracy of intraocular pressure measurements in New Zealand white rabbits10.1167/iovs.04-0610 ↗
47. A method for the routine intraocular pressure (IOP) measurement in the rabbit: range of IOP variations in this species10.1016/0014-4835(77)90149-X ↗
48. Hierarchical nanoengineered surfaces for enhanced cytoadhesion and drug delivery10.1016/j.biomaterials.2011.01.022 ↗
49. Nanoengineered surfaces enhance drug loading and adhesion10.1021/nl103951e ↗
50. Shape effect in the design of nanowire coated microparticles as transepithelial drug delivery devices10.1021/nn3019865 ↗